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The role that interleukin-2 (IL-2) plays in T-cell development is not known. To address this
issue, we have investigated the nature of the abnormal thymic development and autoimmune
disorders that occurs in IL-2-deficient (IL-2-/-) mice. After 4 to 5 weeks of birth, IL-2
-/- mice
progressively develop a thymic disorder resulting in the disruption of thymocyte maturation.
This disorder is characterized by a dramatic reduction in cellularity, the selective loss of
immature CD4-8- (double negative; DN) and CD4+8 (double positive; DP) thymocytes and
defects in the thymic stromal-cell compartment. Immunohistochemical staining of sections of
thymuses from specific pathogen-free and germ-free IL-2
-/- mice of various ages showed a
progressive ,loss of cortical epithelial cells, MHC class II-expressing cells, monocytes, and
macrophages. Reduced numbers of macrophages were apparent as early as week after birth.
Since IL-2
-/- thymocyte progenitor populations could mature normally on transfer into a normal
thymus, the thymic defect in IL-2
-/- mice appears to be due to abnormalities among thymic
stromal cells. These results underscore the role of IL-2 in maintaining functional micro-
environments that are necessary to support thymocyte growth, development, and selection.
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INTRODUCTION
Thymocyte development is dependent on the intimate
association with stromal cells and the cytokine milieu
of the thymus (reviewed in Carding and Reya, 1994).
Among the cytokines that are normally produced
within the thymus during T-cell development, IL-2
has been the most intensively studied. The expression
of functional IL-2Rs by developing thymocytes
(Skinner, et al., 1987; Jenkinson et al., 1987; Waan-
ders et al., 1989, 1990; Zuniga-Pflucker et al., 1990),
and the ability of anti-IL-2R antibodies to disrupt
thymocyte growth and/or proliferation in vivo (Ten-
tori et al., 1988; Zuniga-Pflucker and Kruisbeek,
1990; Tanaka et al., 1992) provide strong evidence for
a direct role for IL-2 in thymocyte development.
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Recent studies analyzing thymocyte development in
IL-2-deficient (IL-2-/-) mice have provided more
direct evidence for a requirement for IL-2 for normal
thymocyte development.
Although the initial analysis of thymocyte develop-
ment in neonatal IL-2
-/- mice did not detect any
changes in the cellularity or composition of thymo-
cytes (Schorle et al., 1991), these animals subse-
quently develop a fatal autoimmune disorder
characterized by hyperactivation of peripheral T cells,
lymphadenopathy, splenomegaly, hemolytic anemia,
and colitis (Sadlack et al., 1993; Horak et al., 1995).
Subsequent studies of IL-2
-/- mice bred onto the
athymic nu/nu background and RAG-2
-/- mice
reconstituted with IL-2
-/- bone marrow have shown
that the immunopathology in these mice depends on
the intrathymic differentiation of T cells carrying the
IL-2 mutation (Krimer et al., 1995). Other studies
identifying phenotypic changes in subsets of thymo-
cytes (Hanke et al., 1994; Lfidvfksson et al., 1997), or
abnormal cytokine production (LfidvNsson et al.,
1997) by IL-2
-/- thymocytes also implicate defects in
thymic development as the underlying basis of
disease pathology in these mice. Finally, our recent
finding that IL-2
-/- mice kept in a germ-free
environment also develop lymphoid hyperplasia and
autoimmunity (Contractor et al., in press) is also
consistent with a defect in central and/or peripheral
tolerance being responsible for disease rather than an
uncontrolled peripheral T-cell response to environ-
mental antigens. Although the evidence in favor of
IL-2 being involved and required for thymocyte
growth, survival, and/or development is compelling;
the questions of how IL-2 influences these processes
and what is the underlying basis of abnormal
thymocyte development in IL-2
-/- mice remain
unanswered.
Here, we have investigated the nature of defective
thymocyte development in IL-2
-/- mice. The poss-
ibility that IL-2 may regulate T-cell development
indirectly by influencing stromal components of the
thymic microenvironment has been ignored or over-
looked in many of the previous studies. To address the
role of IL-2 in thymic development, we have
determined what the consequences of IL-2 deficiency
are on the growth and development of thymocytes and
thymic stromal cells. The results of our analysis show
that the disruption of T-cell development in IL-2
-/-
mice is related to changes in thymic architecture and
deficiencies in specific stromal-cell populations.
RESULTS
Although the autoimmune disorder that develops in
IL-2
-/- mice appears to arise as a consequence of
dysregulated T-cell development (Krimer et al.,
1995; LfidvNsson et al., 1997), thymic development
in these animals has, to date, not been studied in
detail. Our approach, therefore, has been to character-
ize and identify deficiencies and/or defects within the
lymphoid and nonlymphoid populations present
within the thymi of IL-2
-/- mice.
IL-2
-/- Thymocytes Have an Unusual Phenotype
Where as 2- to 4-week-old IL-2
-/- mice had normal
numbers and distribution of thymocytes as reported
previously (Schorle et al., 1991), the thymuses of
older mice progressively decreased in size and by 6 to
8 weeks of age contained up to twentyfold fewer cells
than those of IL-2
+/+ or IL-2
+/- littermates (Table I).
Since the results of the analysis of IL-2
+/+ and IL-2
+/-
thymocytes were equivalent, only those obtained from
IL-2
+/+ mice are shown throughout this study. The
loss of cells was primarily attributable to a reduction
in the number of immature thymocytes, particularly
DP cells (Table I and Fig. 1). A significant, albeit less
dramatic, reduction (approximately two fold) in the
number of CD4 and CD8 SP thymocytes was also
apparent. Consistent with the loss of the most
immature thymocytes was the reduced number of
CD3-, DN thymocytes in the thymuses of IL-2
-/-
mice (Table I). The majority of DN thymocytes
present expressed high levels of CD3 (CD3hi) con-
sistent with there being more mature thymocytes
(Table I and Fig. 2). This proportional increase in the
number of CD3 cells was shown not to be due to the
expansion of y6 T cells since the frequency of "?,6
cells in the thymuses of IL-2
-/- mice of all ages (3 toT-CELL DEVELOPMENT IN IL2 MICE 289
TABLE Thymus Cellularity and Composition in IL-2
-/- Mice
Cell number ( 106)
IL-2 genotype Age (w) n Total DN, CD3- DN, CD3
% thymocytes
DN DP CD4-SP CD8-SP
+/+ 4 5 91 +/- 3 2.8 1.0 1.2 0.4
4 6 123 15 2.7 0.5 0.9 0.5
+/+ 6 7 106 12 2.2 0.2 1.0 0.3
6 8 79 +13 1.9 0.3 1.3 0.6
+/+ 8 5 113 15 1.7 0.5 0.7 0.2
8 6 6 3 0.01 0.01 0.1 _+ 0.1
+/+ 10 8 104 19 2.3 1.2 0.8 +/- 0.2
10 4 4 3 0.01 0.01 0.1 0.1
Germ-free mice
+/+ 6 5 71 14 2.4 0.2 0.8 0.4
6 6 79 20 3.4 0.3 0.5 0.2
+/+ 8 3 84 7 3.4 0.2 0.8 +/- 0.3
8 5 72 9 1.8 0.4 0.4 0.2
+/+ 10 4 88 +/- 11 2.1 0.1 0.5 0.3
10 4 31 10 0.7 0.2 0.6 0.2
3+1 84+15 9+3 5+2
3+2 78+ 10 10+4 8+3
3+2 83+6 8+2 6_+3
4_+2 64_+ 18 19+6 12-+4
2-+2 84_+9 8_+3 6_+3
2_+2 3_+5 51_+ 17 44_+ 12
3+2 80+8 9+3 6_+3
3+2 5+/-3 50+ 10 42+ 11
4+/-2 86+/-12 6+/-3 4_+2
5+/-3 81+/-9 9+/-5 5_+3
5_+2 81+/-8 9+/-3 5_+2
3+/-2 86+/-10 7+/-4 4_+3
3+/-1 85+/-4 8+/-3 4_+2
4+/-2 54+/-12 27+/-5 15_+4
Determined by three-color flow cytometry.
8 weeks) was comparable to that seen in wild-type
mice (Fig. 2). In contrast to DN cells from IL-2
+/+
thymuses, a higher proportion of IL-2
-/- DN cells
expressed CD44 (Fig. 2). Since most of these cells
also express high levels of CD3, CD44 expression is
unlikely in this case to be a marker of immaturity
(Godfrey and Zlotnik, 1993) and reflects the accumu-
lation of progenitor cells unable to develop further in
the absence of IL-2. Although we have not carried out
a more detailed phenotypic analysis of IL-2
-/- DN
thymocyte subsets, the fact that the number of
CD3-CD4-CD8- progenitor cells in IL-2
-/- mice
was never greater than that seen in wild-type
littermates (Table I) is consistent with there being no
block in the development of IL-2
-/- T-cell progeni-
tors. Instead, expession of CD44 may reflect aberrant
activation of CD3 DN cells in the IL-2
-/- thymuses.
This interpretation is supported by the finding that a
higher proportion of mature splenic and lymph-node
T cells in IL-2
-/- mice express these activation-
associated antigens when compared to the same T-cell
populations in wild-type mice (data not shown;
Sadlack et al., 1995). Moreover, in both the spleen
and the lymph node, there was a three- and fourfold
expansion of both the CD8 and CD4 T cells compared
to the T cells in wild-type mice similar to that
described by Sadlack et al., (1995).
IL-2
-/- Thymocyte Defect Is Rescued After
Transfer to a Normal Thymic Microenvironment
To determine whether the loss of DN and DP
thymocytes in IL-2
-/- mice were due to an inherent
requirement for IL-2 and an intrinsic developmental
defect, or disruption in the microenvironment, to 2
105 TN thymocytes from 4-week-old wild-type and
IL-2
-/- mice (Thy 1.2+) were transferred to the
thymus of wild-type mice. At this age, the IL-2
-/-
thymus is intact with cellularity and composition of
thymocytes similar to that of IL-2
+/+ littermates
(Table 1). The selected thymocytes contained less
than 2% CD4+, CD8+, or Ig-coated cells and between
1% and 2% expressed low levels of CD3. The
estimated cell recovery was approximately 85%. One
to two hundred thousand cells were injected into each
thymic lobe of sublethally irradiated Thy 1.1
C57BL.6 mice. At 4 to 5 weeks after transfer, none of
the animals (n 4) receiving IL-2
-/- thymocytes
showed any clinical signs of disease, and at necropsy,
the thymus, spleen, lymph nodes, and colon were290 T. REYA et al.
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FIGURE Loss of immature thymocytes in IL-2
-/- mice. Thymocytes from 5-week-old SPF IL-2
-/- (-/-) or IL-2
+/+ (+/+) littermates
were stained with PE-conjugated anti-CD4, FITC-conjugated anti-CD8 (upper dot plots), and biotinylated anti-CD3 and strepavidin-Red
670. The values shown represent the frequency of positive cells in each quadrant. The lower histograms show the level of CD3 expression
by different subsets of CD4- and CD8-expressing thymocytes. The values shown represent the frequency of positive cells. The results shown
are representative of those obtained from eight IL-2
-/- and seven IL-2
+/+ mice.T-CELL DEVELOPMENT IN IL2 MICE 291
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FIGURE 2 Analysis of CD4-8- (double negative; DN) thymocytes in IL-2
-/- mice. Thymocytes from 5-week-old SPF IL-2
-/- (-/-)
and IL-2
+// (+/+) mice were stained with PE-conjugated anti-CD4, FITC-conjugated anti-CD8 and either biotinylated anti-CD3, anti-TCR y6,
or anti-CD44 and strepavidin Red 670. DN thymocytes were reanalyzed for expression of CD3 (upper histogram), y(3 cells (middle
histogram), and CD44 (lower histogram). The values shown represent the frequency of positive cells. The results shown are representative
of those obtained from eight IL-2
-/- and seven IL-2
+/+ mice.292 T. REYA et al.
grossly and histologically normal (data not shown).
Immunoflourescence and flow cytometric analysis of
thymocyte and spleenz-cell populations from recon-
stituted animals revealed that donor-derived cells
comprized approximately 3% of thymocytes and
10-15% of splenic T cells (data not shown) present in
the host. There was no significant difference in the
degree of chimerism using thymocytes from IL-2
-/-
versus IL-2
+/+ mice.
Importantly, thymocytes from the IL-2
-/- mice
exhibited normal developmental potential as deter-
mined by the generation of DP and SP thymocytes
(Fig. 3), which was comparable to that seen from IL-
2
+/+ thymocytes. TCRcq3 and TCRy6 thymocytes
were present in normal proportions in the thymuses of
animals receiving IL-2
+/+ or IL-2
-/- thymocytes.
These results demonstrate that the aberrant T-cell
development that occurs in IL-2
-/- mice does not
occur in a normal, intact thymic microenvironment,
suggesting that the defects may be caused by
microenvironmental defects in the IL-2
-/- mice.
Consistent with this interpretation was the "normal"
phenotype of IL-2
-/- splenic T cells generated in a
wild-type thymus that, unlike the splenic and lymph
node T cells that develop in IL-2
-/- thymuses and
mice, did not express the activation-associated anti-
gen CD44 (data not shown).
The Absence of IL-2 Causes a Disruption in
Thymic Architecture and Thymic Stromal-Cell
Abnormalities
Since thymocyte development is dependent on the
interaction with thymic stromal cells, we examined
IL2
IL2
+/+
CD4
Host Donor Donor
" 2.9%
CD3
81.8%
CD8 CD3
FIGURE 3 CD3-4-8- (triple negative; TN) thymocytes from IL-2 mice can develop normally on transfer to the thymus of wild-type
mice. Two hundred thousand Thy 1.2 TN from 4-week-old SPF IL-2
-/- (-/-) or IL-2
+/+ (+/+) littermates (donor cells) were injected into
the thymuses of Thy 1.1 C57BL.6 mice (host), and 4 to 5 weeks later, the animals were euthanized and the thymuses analyzed for the
presence of CD4-, CD8-, and CD3-expressing cells that were Thy 1.2 (donor) or Thy 1.1 (host) using three-color flow cytometric analysis
as described in the legend of Fig. 1. The values represent the frequency of positive cells. The results shown are representative of those
obtained from four animals.T-CELL DEVELOPMENT IN IL2 MICE 293
the possibility that the nonlymphoid elements of the
thymic microenvironment were affected by the
absence of IL-2, resulting in disrupted lymphopoiesis.
An immunohistochemical approach was used to
obtain evidence for changes in the number, distribu-
tion, morphology, and phenotype of the three differ-
ent groups of stromal cells in IL-2
-/- thymuses
(mesenchyme-derived fibroblasts, epithelial cells
[EC], and bone-marrow-derived monocytes/macro-
phages and dendritic cells [DC]). Previously
characterized antibodies representative of those spe-
cific for each stromal-cell type were used for this
study. Thymuses from neonatal (1 to 4 weeks of age)
and adult (5 to 8 weeks of age) IL-2
-/- and IL-2
+/+
mice (using at least four thymuses per age group)
housed under conventional conditions and 8- to
12-week-old germ-free IL-2
-/- and IL-2
+/+ mice were
used for this study.
Nonhematopoietic Stromal Cell Elements
As noted before, after 4 weeks of age, the thymuses of
IL-2
-/- mice were smaller and contained fewer
thymocytes, particularly cortical thymocytes, than
those from IL-2
+/+ littermates. Staining with the
medullary and cortical EC-specific antibodies, ER-
TR5 and ER-TR4, respectively (van Vliet et al.,
1984), revealed abnormal architecture in the IL-2
-/-
thymus (Fig. 4). In contrast to thymuses from IL-2
+/+
mice, the medulla was predominant in the thymuses
of IL-2
-/- mice (Fig. 3). In sections of IL-2
-/-
thymuses, the ER-TR4 cells were intensely stained
and restricted to the outer edges of the thymus,
comprising a thin band of positive cells extending
from the subcapsule into the medulla. A similar
change in the appearance of cortical EC was also seen
in the thymuses of 12-week-old germ-free IL-2
-/-
mice (data not shown). Of note, the loss of ER-TR4
cortical EC in the IL-2
-/- thymuses paralleled the
loss of immature DN and DP thymocytes. Micro-
scopic analysis of stained cells at higher magnifica-
tion revealed that ER-TR4 cells in IL-2
-/- thymuses
were also morphologically different from those in the
IL-2
+/+ thymuses (Fig. 4), being more voluminous and
intensely stained. Since the extent of cellular hetero-
geneity of ER-TR4 cells or the biochemical nature of
the antigen(s) recognized by this antibody is not
known, the significance of this change in cortical EC
morphology and phenotype remains unclear. These
changes in the appearance and distribution of thymic
cortical EC were first evident between 4 and 5 weeks
of age.
The medullary, ER-TR5+, EC in the IL-2
-/- thymi
were indistinguishable from those in IL-2
+/+ thy-
muses, which appeared as dense interwoven networks
of large semireticular cells with short cytoplasmic
processes (Fig. 4). Although the number and mor-
phology of medullary EC was not affected by the
absence of IL-2, there was a progressive loss ofMHC
class II expressing cells in the medulla. This loss
resulted in the virtual absence of any MHC class II-
expressing cells by 6 to 8 weeks of age (Fig. 4). Since
medullary EC represent a major MHC class II
population in the medulla, this observation suggests
that IL-2 can regulate the expression ofMHC calss II
on medullary. By contrast, MHC class I expression
was unaffected in newborn, neonatal, and adult IL-
2
-/- mice, with the distribution and level of
expression being equivalent to that seen in the
thymuses of IL-2
+/+ littermates (data not shown). The
loss of MHC class II molecules on thymic stromal
cells was first evident in mice at approximately 5
weeks of age EC. (data not shown).
Staining with the mesenchymal cell-specific anti-
body ER-TR7 revealed no obvious differences in the
distribution of fibroblasts in the thymuses of 1- to
4-week-old IL-2
-/- and IL-2
+/+ mice (data not
shown). The thymuses of 5- to 8-week-old IL-2
-/-
mice did, however, contain more TR7 cells, and
staining with the Picro-Ponceau cytochemical stain
showed increased deposition of collagen within the
subcapsular layer and underlying cortex consistent
with increased fibroblast proliferation (data not
shown).
Stromal Cells of Hematopoietic Cell Origin
Another striking feature of the thymic stroma of
conventional (5- to 8-week-old) and germ-free (8- to
12-week-old) IL-2
-/- mice was the loss or absence ofT-CELL DEVELOPMENT IN IL2 MICE 295
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FIGURE 5 Loss of MHC class II expression and bone-marrow-derived stromal cell elements in the thymus of IL-2
-/- mice. Frozen
sections of thymuses from 5-week-old SPF IL-2
+/+ (+/+) and IL-2
-/- (-/-) mice were stained with the anti-macrophage-specific antibodies
Mac-1 (A and B) and F4/80 (C and D), and with the anti-thymic dendritic-cell antibody MIDC-8 (E and F) and the anti-MHC class II-specific
antibody Y-3P (G and H). Bound antibody was visualized as described in the legend to Fig. 4. The arrow heads in E and F identify positively
stained dendritic cells, m: medulla; c: cortex. Magnification: 200.296 T. REYA et al.
bodies used was due to the downmodulation or loss of
surface antigens. Analysis of the other major bone-
marrow-derived component of the thymic stroma,
dendritic cells (DC), detected no discernible differ-
ences in the number or distribution of cells staining
with the DC-specific antibody, MIDC-8 (Breel et al.,
1987), in the thymuses of SPF (Fig. 4) and germ-free
(data not shown) IL-2
-/- and IL-2
+/+ mice. However,
since thymic DC normally show strong expression of
MHC class II molecules and in view of the reduced
level of MHC class II staining in IL-2
-/- thymuses
the functional properties of thymic DC may be
adversely affected by the absence of IL-2.
Changes in the number and distribution of thymic
macrophages were first evident in the thymuses of
6-day-old IL-2
-/- mice, which already contained
fewer cortical and medullary F4/80 cells (Fig. 6). As
the IL-2
-/- mice aged, the loss or absence of
macrophages became more severe, particularly in the
medulla, which by 3 to 4 weeks was essentially
devoid of any Mac-1-, Mac-3-, and/or F4/80-express-
ing cells.
Thymic Stromal Cells in Germ-Free IL-2
-/-
Mice
Since germ-free IL-2
-/- mice develop disorders of
the hematopoietic and immune systems similar to that
seen in specific pathogen-free IL-2
-/- mice (Con-
tractor et al., in press), we evaluated them for the
thymic stromal-cell abnormalities seen in SPF IL-
2
-/- mice. Changes in cellularity and composition of
the thymuses of germ-free IL-2
-/- mice were
detected after 8 weeks of age (Table I), coincident
+/+ -/-
FIGURE 6 Loss of macrophages in the thymuses of neonatal IL-2 mice. Frozen sections of thymuses from 6-day-old SPF IL-2 (+/+)
and IL-2
-/- (-/-) mice were stained with the F4/80 antibody as described in the legend to Fig. 5. The results shown represent F4/80 staining
of thymuses from two IL-2
+/+ (A and C) and two IL-2
-/- (B and D) littermates, m: medulla; c: cortex. Magnification: 200.T-CELL DEVELOPMENT IN IL2 MICE 297
with the appearance of other signs of disease (e.g.,
anemia). Changes in thymic stromal-cell populations
were evident at 6 weeks of age (Fig. 7), and as seen in
the thymuses of SPF IL-2
-/- mice, bone-marrow-
derived macrophages were particularly affected. Cor-
tical epithelial cells were also reduced in number, and
the level of MHC class II staining was also reduced
compared to that seen in sections of thymuses from
germ-free IL-2
+/+ animals (data not shown).
In summary, the absence of IL-2 results in the
disruption of T-cell development, which appears to be
attributable to changes in thymic architecture and
deficiencies in specific stromal-cell populations.
DISCUSSION
The fatal immunopathology that develops in IL-2
-/-
mice is dependent on the thymic generation of T cells
carrying the IL-2 mutation (Krimer et al., 1995),
consistent with many previous studies demonstrating
a role for IL-2 in normal thymocyte development
(reviewed in Carding and Reya, 1994). The way in
which IL-2 influences T-cell development and the
underlying basis of dysfunctional thymocyte develop-
ment in IL-2
-/- mice is, however, unknown. The
results of our analyses of thymic development in IL-
2
-/- mice have identified abnormalities and defi-
ciencies within populations of stromal cells that we
interpret as being the primary cause of dysregulated
T-cell development in IL-2
-/- mice.
The rescue of IL-2
-/- T-cell-progenitor cell
development on transfer to wild-type thymuse sug-
gests that these cells are not intrinsically defective and
that they can undergo normal IL-2-independent
development. Instead, the occurrence of stromal-cell
defects and deficiencies in the thymi of IL-2
-/- mice
+/+
Mac-1
F4/80
FIGURE 7 Loss of macrophages in the thymus of germ-free IL-2
-/- mice. Frozen sections of thymuses from 6-week-old germ-free IL-2
+/+
(+/+) and IL-2
-/- (-/-) mice were stained with the anti-macrophage-specific antibodies Mac-1 (A and B) and F4/80 (C and D), and bound
antibody was visualized as described in the legend to Fig. 4. m: medulla; c: cortex. Magnification: 200.298 T. REYA et al.
are consistent with abnormal microenvironments
being responsible for dysfunctional thymocyte
development in these animals. Although few reagents
are available to analyze thymic stromal cells, our
studies suggest that the disruption of thymic micro-
environments is attributable to the presence of
abnormal populations of cortical stromal cells, a
progressive loss of MHC class II expression, and
bone-marrow-derived macrophages. Together, these
defects would severely compromise T-cell repertoire
selection and could account for the presence of
autoreactive CD4 T cells and autoimmunity in IL-
2
-/- mice. The presence of thymic stromal-cell
abnormalities in germ-free mice, in which the appear-
ance of hyperactivated T cells is delayed, suggests
that the stromal-cell abnormalities are unlikely to be a
consequence of the activity of dysfunctional T cells.
The failure to detect any effect of the absence of IL-2
on thymic repertoire selection of a MHC class I-
restricted CD8 T cells (Krimer et al., 1994) is not
surprising in view of the normal distribution ofMHC
class I expression in the thymuses of IL-2
-/- mice
(Fig. 3). Yet, the possibility that IL-2/IL-2R signaling
is involved in CD4 T-cell repertoire selection cannot
be excluded. Our recent finding that thymocytes from
ovalbumin-specific, I-A-restricted, TCR-transgenic
mice treated with antigen produce IL-2 while under-
going negative selection and the deletion of antigen-
specific CD4+CD8 thymocytes in vivo is abrogated
in the presence of anti-IL-2R antibodies (Bassiri et al.,
submitted for publication) are consistent with IL-
2/IL-2R interactions being directly involved in clonal
deletion of MHC class II-restricted thymocytes.
The changes in thymic stromal cells in IL-2
-/-
mice could, in principle, be attributable to either an
intrinsic defect and direct requirement for IL-2, or
extrinsic factors and indirect effects of the absence of
IL-2. A direct requirement for IL-2 by bone-marrow-
derived thymic stromal cells is suggested by the
finding that IL-2 is required for growth and develop-
ment of myeloid cells and its absence in IL-2
-/- mice
results in abnormal development of granulocytes and
tissue-specific macrophages (Reya et al., 1998). In
addition, the finding that functional IL-2Rs are
normally expressed by Mac-1 (Thy 1-, CD4-,
CD8-) MHC class II phagocytic (macrophage) cells
(Rocha et al., 1988) and that IL-2 can promote their
growth and interaction with DN and cortical thymo-
cytes (El Rouby et al., 1985; E1 Rouby and Papiernik,
1987) are consistent with this hypothesis. Require-
ment of cytokines produced by thymic macrophages
for normal thymocyte development could also explain
the breakdown in IL-2
-/- thymocyte progenitor
development.
It has been proposed that the hematopoietic and
immune system disorders that develop in IL-2
-/-
mice are caused by lymphoid hyperplasia and T-cell
infiltration into various tissues (Krimer et al., 1995;
Sadlack et al., 1995). Although we cannot exclude the
possibility that dysfunctional T cells contribute to or
exacerbate the thymic defects in these mice, the fact
that stromal-cell defects are apparent in neonatal IL-
2
-/- mice that have very few peripheral T cells and
show no signs of disease makes it unlikely they are
the cause of this disorder.
Since the cortical and medullary macrophage
populations are initially intact in the thymuses of
neonatal (1- to 3-day-old) IL-2
-/- mice, IL-2 may
function primarily as a survival factor for these cells.
Consistent with such an effect of IL-2 on myeloid
cells is its ability to promote the survival in vitro of
mature neutrophils (Pericle et al., 1994). A differ-
ential requirement for IL-2 by thymic macrophages
during neonatal and adult stages of T-cell develop-
ment is another attractive possibility in light of other
studies demonstrating age-related changes in both the
developmental potential of macrophage progenitor
populations and the microenvironments in which they
develop (Naito, 1993; Naito et al., 1996). The
observation that other bone-marrow-derived stromal
cells (dendritic cells) are intact in IL-2
-/- thymuses
suggests that the loss of thymic macrophages is not
related to stress and the systemic production of
corticosteroids. Although the expression of functional
IL-2Rs by EC has been described (Weidmann et al.,
1992; Ciacci et al., 1993), we have been unable to
detect expression of IL-2R-mRNA or cell-surface
protein in freshly isolated or primary cultures of
thymic EC (SRC unpublished observations). The
changes seen among cortical epithelial cells in the IL-T-CELL DEVELOPMENT IN IL2 MICE 299
2
-/- thymuses may, therefore, be a consequence of
indirect effects of the absence of IL-2. The ability of
thymocytes to influence the growth of thymic epi-
thelial cells by direct cell contact (Surh et al., 1992;
Palmer et al., 1993) and through the production of
growth factors (Carding and Reya, 1994) may explain
the presence of abnormal epithelial cells in the
thymuses of IL-2
-/- mice. Regardless of the causes
of these changes, the progressive loss of macrophages
and disruption of thymic stromal microenvironments
provide an explanation why T-cell development is
initially intact in neonatal IL-2
-/- mice and autoim-
munity is only apparent in older animals.
Although our findings are most consistent with
abnormalities in thymic stromal cells being respons-
ible for the disruption in thymocyte development in
IL-2
-/- mice, we cannot entirely exclude the poss-
ibility that IL-2 may also be required for thymocyte
growth and development. Although the rescue of IL-
2
-/- T-cell-progenitor cell development on transfer to
wild-type thymuses suggests that IL-2 is not required
for T-cell-progenitor development, it is possible that
their development is influenced by the IL-2 produced
by the wild-type, host-derived, DN thymocytes
(Yang-Snyder and Rothenberg, 1993; Zlotnik and
Kelner, 1994) that are also present in the reconstituted
thymuses. Since cortical thymocytes are susceptible
to corticosteroid-induced death, it is possible that
stress and steroid production may contribute to, or
exacerbate, the disruption in thymocyte development
and loss of DP thymocytes. Additional experiments
are required to address these possibilities.
In summary, our data demonstrate that IL2 is
required in order to promote the development and
maintenance of the nonlymphoid stromal-cell popula-
tions that comprise the thymic microenvironments
necessary for the support of T-cell-progenitor cell
growth and development.
MATERIALS AND METHODS
Mice
C57BL.6-Thy.1 (B6.PL-Thyl’/Cy)-congenic mice
were obtained from the Jackson Laboratory (Bar
Harbor, ME) and were used between 4 and 6 weeks of
age. Specific pathogen-free (SPF) IL-2
-/- mice
backcrossed for eight generations to C57BL.6 were
obtained from R. Schwartz (NIH, Bethesda, MD).
The mice were bred and maintained in individual
filter cages at the University of Pennsylvania and
were used between 1 and 7 weeks of age. Sentinel
animals housed with the mutant mice were routinely
screened for the presence of common mouse patho-
gens and none has been detected at any time since the
animals have been in our facility. Eight- to twelve-
week-old gnotobiotic (germ-free) IL-2
-/- and IL-2
+/+
and IL-2
+/- mice were rederived from our SPF colony
of IL-2
-/- mice by Taconic Farms (Germantown,
NY) and were certified as being free of any viral and/
or bacterial organisms. The mice were fed a sterile
(autoclaved) mouse diet (PMI Feeds, St Louis) and
were housed in isolator cages within a flexible film
isolator in the gnotobiotic facility of the Biology
Department at the University of Pennsylvania. The
germ-free status of all animals used was verified by
bacteriological, histological, and serological analyses
of tissues and fluids at autopsy. Homozygous animals
were derived from homozygote (germ-free animals)
or heterozygote (SPF and germ-free animals) matings
and were identified from samples of tail DNA by PCR
(Schorle, 1991). Heterozygote sex-matched litter-
mates were used as controls for all experiments using
IL-2
-/- animals or cells. The frequency and age of
onset of anemia and colitis in homozygous animals
maintained in our facility were the same as previously
reported (Sadlack et al., 1993).
Cell Isolation and Intrathymic Transfer
CD4-, CD8-, CD3- (triple negative; TN) thymo-
cytes from IL-2
-/- and IL-2
+/+ (Thy 1.2+) mice were
isolated using a negative immunomagnetic isolation
procedure (Belles et al., 1996) incorporating anti-CD4
(clone GK1.5; American Tissue Type Culture Collec-
tion [ATCC], Rockville, MD), anti-CD8 (TIB210;
ATTC), and anti-CD3 (29B; Life Technologies,
Gaithersburg, MD), and goat anti-mouse/rat Ig-coated
immunomagnetic particles (BioMag Beads, Perse-
ptive Diagnostics, Cambridge, MA). All incubations300 T. REYA et al.
were carried on ice for 15 to 20 min to minimize any
downmodulation of surface antigens. The purity of
the selected cell population was verified by flow
cytometry and was routinely > 98% CD4-8- and >
92% CD3- (Fig. 1) with the residual CD3-expressing
cells being CD3l, similar to immature CD3 DN
thymocytes (Fig. 1). Between and 2 105 IL-2
-/-
or IL-2
+/+ TN thymocytes were injected in a volume
of 10 to 20/xl of PBS into each lobe of the thymuses
of sublethally irradiated (650 R) Thy 1.1 C57BL.6
mice. Approximately, 4 weeks later, animals were
euthanized and the thymus and spleen analyzed for
donor cells by flow cytometry using antibodies
reactive with the donor-specific allele of Thy (Thy
1.2).
Flow Cytometry
The following mouse and rat monoclonal antibodies
were used to stain and analyze thymocytes isolated
from IL-2
-/- and IL-2
+/+ mice. CD90/Thy 1.2
(30H.12; Life Technologies); CD90/Thyl.1 (HIS51;
Pharmingen, San Diego); CD3 (29B; Life Technolo-
gies); CD4 (CT-CD4; Caltag Laboratories, San Fran-
cisco); CD8ce (5.3-6.7; Life Technologies); CD24/
HSA (M1/69; Pharmingen); CD25/IL-2Rce (PC61;
ATCC); CD44/Pgp-1 (IM7; Pharmingen); CD69
(H1.2F3; Pharmingen); CD122/IL-2R/3 (TM/31; Phar-
mingen); TCRcq3 (H57-597; Pharmingen), TCRy
(GL3; Pharmingen). Stepavidin-phycoerythrin and
strepavidin-Red670 (SA-PE, SA-Red670; Life Tech-
nologies) were also used to detect reactivity of
biotinylated primary antibodies. Antibody staining
and flow cytometric analysis were carried out using a
FACScan and Lysis II or CellQuest software (Becton-
Dickinson, San Jos6, CA), as described previously
(Reya et al., 1996).
serum/5% normal rabbit serum in 10 mM Tris, pH
7.3, 0.15 M NaC1, and 0.02% Triton 100 [TBST])
prior to incubation with primary antibodies. At least
four independently obtained thymus samples from IL-
2
-/- and IL-2
+/+ mice of each age group were used for
this analysis. Optimal concentrations of monoclonal
antibodies reactive with cortical (ER-TR4; van Vliet
et al., 1984) or medullary (ER-TR5; van Vliet et al.,
1984) epithelial cells, fibroblasts, and other con-
nective tissue elements (ER-TR7; van Vliet et al.,
1984), monocytes/macrophages (CD lb/Mac- [M1/
70], Caltag; F4/80, Caltag; Mac-3, Pharmingen),
interdigitating dendritic cells (MIDC-8; Serotec,
Oxford, UK), orMHC class I (Y-3; ATCC) and II (Y-
3P; ATCC) molecules were prepared in TBST and
incubated with sections at 20C for 60 min. Isotype-
matched rat and mouse IgG antibodies of irrelevant
specificity were used as controls. The sections were
washed with TBST and incubated with either a biotin-
labeled mouse anti-rat IgG (Vector Laboratories,
Burlingame, CA) or biotin-labeled rabbit anti-mouse
IgG (Vector) monoclonal antibody, washed, and
incubated with a biotin-avidin-alkaline phosphatase
complex (Vector). The Vector Red (Vector) alkaline
phosphatase substrate kit was used to visualize
antibody-labeled cells and sections were counter-
stained with methyl green prior to mounting and
photomicroscopy.
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Immunohistochemistry
Frozen sections (5/zm) of newborn (1- to 3-day-old),
neonatal (1- to 3-week-old), and adult (4- to 7-week-
old) IL-2
-/- and IL-2
+/+ thymuses were fixed in ice-
cold acetone, incubated with blocking solution (5 #g/
ml mouse IgG [Sigma, St. Louis]/5% normal rat
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